Rapid remission of life‐threatening chylo‐ascites with dabrafenib and trametinib combination in complex lymphatic anomaly with pathogenic somatic BRAF and PIK3CA co‐variation
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Mathias Yuan, Ingo Königs, Konrad Reinshagen, Jan‐Malte Ambs, Stefan Rutkowski, Uwe R. Kordes |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
by: Nisreen Amayiri, et al.
Published: (2024)
by: Nisreen Amayiri, et al.
Published: (2024)
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
by: Wallace Bourgeois, et al.
Published: (2024)
by: Wallace Bourgeois, et al.
Published: (2024)
NRAS melanoma response to trametinib and azacitidine
by: Shannon Wessel, et al.
Published: (2024)
by: Shannon Wessel, et al.
Published: (2024)
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib
by: Isaac Hauk, et al.
Published: (2024)
by: Isaac Hauk, et al.
Published: (2024)
Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
by: Rozalyn Chok, et al.
Published: (2026)
by: Rozalyn Chok, et al.
Published: (2026)
Experience with trametinib in a pediatric patient with MAP2K1‐related cervicofacial arteriovenous malformation
by: Neeraja Swaminathan, et al.
Published: (2024)
by: Neeraja Swaminathan, et al.
Published: (2024)
Two cases of severe cutaneous toxicity induced by trametinib in children with neurofibromatosis type 1 and a brief review of the literature
by: Joan Ceravalls, et al.
Published: (2024)
by: Joan Ceravalls, et al.
Published: (2024)
Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant
by: Michael D. Fox, et al.
Published: (2025)
by: Michael D. Fox, et al.
Published: (2025)
Spontaneous remission in a case of neonatal leukemia with KMT2A gene rearrangement
by: Yuki Yasudome, et al.
Published: (2024)
by: Yuki Yasudome, et al.
Published: (2024)
Complete remission of EWSR1–KLF15 myoepithelial carcinoma of the soft tissue following pazopanib monotherapy
by: Jasmine Smith, et al.
Published: (2024)
by: Jasmine Smith, et al.
Published: (2024)
Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis
by: Amy Li, et al.
Published: (2024)
by: Amy Li, et al.
Published: (2024)
Molecularly Informed Combination Therapy for BRAF‐KIAA1549 Fusion‐Positive Pilocytic Astrocytoma in a Resource‐Limited Setting
by: Yousef VatanParast
Published: (2025)
by: Yousef VatanParast
Published: (2025)
Concurrent primary mediastinal germ cell tumor and acute myeloid leukemia: Case report of sustained remission and review of the literature
by: Kristina Zalewski, et al.
Published: (2024)
by: Kristina Zalewski, et al.
Published: (2024)
Access Program for Unapproved and Off‐Label Drug Use in Pediatric BRAF V600E‐Mutated Brain Tumors in Japan
by: Maya Suzuki, et al.
Published: (2025)
by: Maya Suzuki, et al.
Published: (2025)
Ocular Safety and Visual Acuity Stability in Pediatric Patients With Optic Pathway Gliomas and Orbital Plexiform Neurofibromas Treated With BRAF and MEK Inhibitors
by: Aviv Sever, et al.
Published: (2025)
by: Aviv Sever, et al.
Published: (2025)
Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation
by: Hannah Sultan, et al.
Published: (2026)
by: Hannah Sultan, et al.
Published: (2026)
Rare association of VACTERL anomaly with sacrococcygeal teratoma
by: Sathya Murugasamy, et al.
Published: (2024)
by: Sathya Murugasamy, et al.
Published: (2024)
BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
by: Chan‐Juan Wang, et al.
Published: (2024)
by: Chan‐Juan Wang, et al.
Published: (2024)
A Rare Case of Pediatric BRAF V600E‐Mutated Erdheim–Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation
by: Jing Ni, et al.
Published: (2026)
by: Jing Ni, et al.
Published: (2026)
Dyadic coping experiences of parents of children with vascular anomalies
by: Anna M. Kerr, et al.
Published: (2024)
by: Anna M. Kerr, et al.
Published: (2024)
Comment on: “Challenging the Odds: Long‐Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co‐Mutations Treated With Upfront Radiotherapy and Targeted Therapy”
by: Natália Dassi, et al.
Published: (2026)
by: Natália Dassi, et al.
Published: (2026)
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features
by: Andrew C. Hinchliffe, et al.
Published: (2024)
by: Andrew C. Hinchliffe, et al.
Published: (2024)
Effects of L-carnitine supplementation on ascites syndrome in the broilers grown at high altitude
by: Muhammed İkbal Coşkun
Published: (2019)
by: Muhammed İkbal Coşkun
Published: (2019)
A case of co‐occurring acute myeloid leukemia and relapsed diffuse large B‐cell lymphoma in a young adult with Shwachman–Diamond syndrome
by: Francis R. LeBlanc, et al.
Published: (2024)
by: Francis R. LeBlanc, et al.
Published: (2024)
Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980–2019: An analysis of 40 years based on data from the German Childhood Cancer Registry
by: Maike Wellbrock, et al.
Published: (2024)
by: Maike Wellbrock, et al.
Published: (2024)
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies
by: Maximilian Klink, et al.
Published: (2024)
by: Maximilian Klink, et al.
Published: (2024)
Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020
by: Mona P. Ankerstjerne, et al.
Published: (2024)
by: Mona P. Ankerstjerne, et al.
Published: (2024)
Aggressive Systemic Mastocytosis Related to Germline p.D816V KIT Mutation
by: Antonia Kiwit, et al.
Published: (2025)
by: Antonia Kiwit, et al.
Published: (2025)
Long-term stability of trastuzumab in plasma and whole blood samples stored under different conditions
by: Jonathan González-García
Published: (2019)
by: Jonathan González-García
Published: (2019)
Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma
by: Theo Marguet, et al.
Published: (2024)
by: Theo Marguet, et al.
Published: (2024)
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)
by: Stefan S. Bielack, et al.
Published: (2024)
by: Stefan S. Bielack, et al.
Published: (2024)
Effects of consuming different doses of red wine on male blood pressure
by: Everaldo de Araujo Barbosa Filho
Published: (2019)
by: Everaldo de Araujo Barbosa Filho
Published: (2019)
Challenging the management of bleeding and coagulopathy in ascending aortic surgery in a Jehovah's Witness patient: case report
by: Katheryne Chaparro-Mendoza
Published: (2019)
by: Katheryne Chaparro-Mendoza
Published: (2019)
Analysis of the intraoperative use of red blood cells and reserve index/transfusion at a University Hospital in Bogotá, Colombia
by: Katherine Caita-Rizo
Published: (2018)
by: Katherine Caita-Rizo
Published: (2018)
Impact on early and late mortality after blood transfusion in coronary artery bypass graft surgery
by: Antonio Alceu dos Santos
Published: (2013)
by: Antonio Alceu dos Santos
Published: (2013)
Expanding the Malignancy Spectrum of Tatton‐Brown–Rahman Syndrome: A Case of Hodgkin Lymphoma
by: Shreyasi Das, et al.
Published: (2026)
by: Shreyasi Das, et al.
Published: (2026)
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee
by: Jessica D. Daley, et al.
Published: (2025)
by: Jessica D. Daley, et al.
Published: (2025)
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition
by: Gabriela Ramirez‐Cuebas, et al.
Published: (2025)
by: Gabriela Ramirez‐Cuebas, et al.
Published: (2025)
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome
by: Atsushi Sakamoto, et al.
Published: (2024)
by: Atsushi Sakamoto, et al.
Published: (2024)
Reflections on 20 years of the Wilms Africa project: Lessons learned and the way forward
by: Trijn Israels, et al.
Published: (2024)
by: Trijn Israels, et al.
Published: (2024)
Similar Items
-
BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas
by: Nisreen Amayiri, et al.
Published: (2024) -
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia
by: Wallace Bourgeois, et al.
Published: (2024) -
NRAS melanoma response to trametinib and azacitidine
by: Shannon Wessel, et al.
Published: (2024) -
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib
by: Isaac Hauk, et al.
Published: (2024) -
Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
by: Rozalyn Chok, et al.
Published: (2026)